Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy (HPDSC+HIE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02434965
Recruitment Status : Withdrawn (Study not started)
First Posted : May 6, 2015
Last Update Posted : February 23, 2021
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
New York Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : January 2022